Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > 15$ ZACKS valuation just a starter

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Oct 11, 2021 9:25am

147 Views

Post# 33994752

RE:15$ ZACKS valuation just a starter

I think $15 is not fair evaluation imo. It has been a while since my last post here. I do not even look at sp anymore. It is a company to hold forever. It will keep going up slowly. I think it will go back to $75. Is that going to be next month few months down the road a year from now. I don't care as long as we get there I can wait

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale